Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

9.32

-0.20 (-2.10%)

At close: Apr 28, 2026, 4:00 PM EDT

9.50

+0.18 (1.93%)

After-hours: Apr 28, 2026, 7:14 PM EDT

Ocular Therapeutix Employees

Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year.

Employees

325

Change (1Y)

Growth (1Y)

18.61%

Revenue / Employee

$159,849

Profits / Employee

-$818,274

Market Cap

2.03B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	325	51	18.61%
Dec 31, 2024	274	7	2.62%
Dec 31, 2023	267	-7	-2.55%
Dec 31, 2022	274	46	20.18%
Dec 31, 2021	228	47	25.97%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Company Name	Employees
Sarepta Therapeutics	835
Ascentage Pharma Group International	767
Adaptive Biotechnologies	624
Zymeworks	264
Capricor Therapeutics	231
Stoke Therapeutics	170
Aurinia Pharmaceuticals	128
Definium Therapeutics	106